Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
November 13, 2020 00:45 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
November 10, 2020 17:40 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Third Quarter and Nine Months 2020 Financial Results
November 09, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting
November 02, 2020 16:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Third Quarter 2020
October 14, 2020 16:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Updates Date and Time of Presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 17, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
September 03, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. Announces Management Change
August 24, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2020 Financial Results
August 10, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Latest Advanced Wound Care Innovations and Research from Organogenesis to be Highlighted at SAWC Spring | WHS 2020 Virtual Meeting
July 23, 2020 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...